GSK Plc won US approval for its drug to treat a deadly lung disease, ramping up competition with rival Sanofi.

ABL Bio Inc., a South Korean biotech company, will license out its proprietary blood-brain barrier shuttle platform, called the Grabody-B, to UK-based pharmaceutical giant GSK plc in a deal expected ...